Answer
Givosiran sodium reduces circulating levels of the neurotoxic intermediates aminolevulinic acid (ALA) and porphobilinogen (PBG) in acute hepatic porphyria.
Sources for this answer
- GivlaariAlnylam UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked